Gontivimab
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung[1].
Product Specifications
CAS Number
1257358-38-5
Product Name Alternative
ALX-0171; VR-465
UNSPSC
12352203
Target
RSV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gontivimab.html
Purity
95.11
Solubility
10 mM in DMSO
Smiles
[Gontivimab]
References & Citations
[1]Detalle L, et al. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2015 Oct 5;60 (1) :6-13.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx353662-01 96 Tests
Rat Embryonic Ectoderm Development (EED) ELISA Kit
Sign In for Pricing
View Details abx353662-02 5x 96 Tests
Rat Embryonic Ectoderm Development (EED) ELISA Kit
Sign In for Pricing
View Details abx353662-03 10x 96 Tests
Rat Embryonic Ectoderm Development (EED) ELISA Kit
Sign In for Pricing
View Details xAP-0177 100 µg
Mouse Monoclonal anti-Human CD218a (IL-18Ra) Antibody
Sign In for Pricing
View Details 
MBS6411927-01 0.1 mL
CLU (Clusterin, Aging-associated Gene 4 Protein, Apolipoprotein J, CLI, AAG4, APOJ, CLU1, CLU2, KUB1, SGP2, APO-J, SGP-2, SP-40, TRPM2, TRPM-2, NA1/NA2) (MaxLight 490)
Sign In for Pricing
View Details